NEW YORK (GenomeWeb) – Luminex today announced it has signed a distribution and supply agreement with Bio-Techne that will last through 2020.
Under the terms of the agreement, Bio-Techne will distribute Luminex instruments, including the Luminex 200, Flexmap 3D, and Magpix, in major markets worldwide. Bio-Techne will also continue to develop and commercialize immunoassays for the Luminex platform.
"With its global scope, Bio-Techne is an ideal partner that can ensure our advanced multiplexing solutions reach the right scientists and researchers," Luminex VP of Global Sales and Customer Operations Todd Bennett said in a statement.
Financial terms of the agreement were not disclosed.
Minneapolis-based Bio-Techne is a global distributor of life sciences tools and reagents.
Last week, Luminex signed an deal with Affymetrix's eBioscience unit to distribute the multiplexed assay instruments in the US, Canada, Mexico, Brazil, China, the Netherlands, Germany, France, the UK, Switzerland, Austria, Belgium, Ireland, Luxembourg, and Poland.